Product NDC: | 46287-014 |
Proprietary Name: | Oracit |
Non Proprietary Name: | Citric Acid and Sodium Citrate |
Active Ingredient(s): | 640; 490 mg/5mL; mg/5mL & nbsp; Citric Acid and Sodium Citrate |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 46287-014 |
Labeler Name: | Carolina Medical Products Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 19840515 |
Package NDC: | 46287-014-30 |
Package Description: | 10 BOTTLE, UNIT-DOSE in 1 CARTON (46287-014-30) > 30 mL in 1 BOTTLE, UNIT-DOSE |
NDC Code | 46287-014-30 |
Proprietary Name | Oracit |
Package Description | 10 BOTTLE, UNIT-DOSE in 1 CARTON (46287-014-30) > 30 mL in 1 BOTTLE, UNIT-DOSE |
Product NDC | 46287-014 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Citric Acid and Sodium Citrate |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 19840515 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Carolina Medical Products Company |
Substance Name | CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
Strength Number | 640; 490 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |